Literature DB >> 21868549

A low-grade myofibroblastic sarcoma in the abdominal cavity.

Miki Miyazawa1, Yoshihiko Naritaka, Akira Miyaki, Shinichi Asaka, Noriyuki Isohata, Kentaro Yamaguchi, Minoru Murayama, Takeshi Shimakawa, Takao Katsube, Kenji Ogawa, Mariko Fujibayashi.   

Abstract

Low-grade myofibroblastic sarcoma (LGMFS) is a fusiform cell tumor which develops in bone or soft tissues. This type of tumor frequently occurs in the oral cavity and extremities, while it is extremely rarely found in the abdominal cavity. This article reports a case of LGMFS exceeding 20 cm in diameter in the abdominal cavity observed in a 65-year-old male patient. The patient visited our hospital complaining of a heavy feeling of the stomach and abdominal distension. Imaging examinations revealed a giant solid tumor in the abdomen, and surgical treatment was scheduled. During the operation, a tumor about 20 cm in diameter with its anterior aspect covered with the greater omentum was found. The tumor had firm adhesions to the surrounding tissues, and it was excised with concomitant resections of the tail of the pancreas and the spleen. Histopathologically, fusiform cells were arranged in a complicated or storiform pattern, and immunohistochemical staining revealed that the tumor was positive for α-smooth muscle actin, negative for S100β, H-caldesmon and c-KIT, and a diagnosis of LGMFS was made.

Entities:  

Mesh:

Year:  2011        PMID: 21868549

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Myofibroblastic sarcoma in liver: a case report.

Authors:  Xiaoping Yi; Desheng Xiao; Xueying Long
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Effective Treatment of Low-Grade Myofibroblastic Sarcoma with Apatinib: A Case Report and Literature Review.

Authors:  Yan Lin; Xing Gao; Ziyu Liu; Zhihui Liu; Yongqiang Li; Rong Liang; Zhiling Liao; Jiazhou Ye
Journal:  Pharmgenomics Pers Med       Date:  2022-06-07

3.  Abnormal liver function induced by myofibroblastic sarcoma infiltrating the liver: A case report.

Authors:  Ye Pan; Xiaolu Wu; Jiajun Liu; Aikeremujiang Muheremu
Journal:  Oncol Lett       Date:  2014-11-27       Impact factor: 2.967

4.  Low-grade myofibroblastic sarcomas of the maxilla.

Authors:  Jin-Yu Qiu; Peng Liu; Ce Shi; Bing Han
Journal:  Oncol Lett       Date:  2014-12-11       Impact factor: 2.967

5.  High-grade myofibroblastic sarcoma in the liver: A case report.

Authors:  Jun Wen; Wei Zhao; Chuan Li; Jun-Yi Shen; Tian-Fu Wen
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

6.  Low-grade Myofibroblastic sarcoma: clinical and imaging findings.

Authors:  Lu Wang; Ling-Xia Li; De-Qiang Chen; Lin Yang; Shu-Kui Li; Cai Cheng
Journal:  BMC Med Imaging       Date:  2019-05-02       Impact factor: 1.930

Review 7.  Low-grade myofibroblastic sarcoma of the levator scapulae muscle: a case report and literature review.

Authors:  Hirotaka Yonezawa; Norio Yamamoto; Katsuhiro Hayashi; Akihiko Takeuchi; Shinji Miwa; Kentaro Igarashi; Mickhael Bang Langit; Hiroaki Kimura; Shingo Shimozaki; Takashi Kato; Sei Morinaga; Yoshihiro Araki; Yohei Asano; Hiroko Ikeda; Takayuki Nojima; Hiroyuki Tsuchiya
Journal:  BMC Musculoskelet Disord       Date:  2020-12-10       Impact factor: 2.362

Review 8.  Low-grade myofibroblastic sarcoma of the orbit: A case report and literature review.

Authors:  Shikun Zhang; Ying Ma; Tie Ma; Zhiming Wang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 9.  Low-grade myofibroblastic sarcoma with abdominal pain, a stuffy nose, hearing loss, and multiple cavity effusion: a case report and literature review.

Authors:  Xueling Wu; Liang Guo; Shaoying Li; Yu Zheng; Bijun Fan; Changxi Zhou
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

10.  Dermatofibrosarcoma metastases to the pancreas: A case report.

Authors:  Huai-Jie Cai; Jian-Hua Fang; Nan Cao; Wei Wang; Fan-Lei Kong; Xi-Xi Sun; Bin Huang
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.